We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class A
BRK.A
$1.06T
| $8.76B | 32.09% |
16,926
-1,526
| -8% | -$760M |
|
2
Microsoft
MSFT
$2.83T
| $1.68B | 6.15% |
4,936,390
-31,221
| -0.6% | -$9.78M |
|
3
Apple
AAPL
$4.72T
| $1.56B | 5.71% |
8,059,125
-117,549
| -1% | -$20.5M |
|
|
4
UnitedHealth
UNH
$385B
| $824M | 3.02% |
1,723,306
+117,417
| +7% | +$57.4M |
|
|
5
Berkshire Hathaway Class B
BRK.B
$1.06T
| $714M | 2.62% |
2,094,013
-25,384
| -1% | -$8.28M |
|
6
Alphabet (Google) Class C
GOOG
$3.88T
| $674M | 2.47% |
5,571,495
-2,878
| -0.1% | -$333K |
|
7
AutoZone
AZO
$47.7B
| $625M | 2.29% |
250,786
+2,451
| +1% | +$6.25M |
|
8
Brookfield
BN
$101B
| $596M | 2.18% |
26,668,266
+28,183
| +0.1% | +$597K |
|
9
Oracle
ORCL
$346B
| $584M | 2.14% |
4,936,478
-51,541
| -1% | -$5.33M |
|
|
10
Danaher
DHR
$135B
| $522M | 1.91% |
2,454,686
+116,932
| +5% | +$24.8M |
|
|
11
Thermo Fisher Scientific
TMO
$213B
| $500M | 1.83% |
961,705
+236,861
| +33% | +$128M |
|
12
KKR & Co
KKR
$86.2B
| $484M | 1.77% |
8,729,853
+322,299
| +4% | +$16.9M |
|
13
Honeywell
HON
$78B
| $298M | 1.09% |
1,534,868
+33,218
| +2% | +$6.17M |
|
14
Lowe's Companies
LOW
$113B
| $280M | 1.03% |
1,248,583
+25,090
| +2% | +$5.22M |
|
15
Visa
V
$669B
| $277M | 1.01% |
1,165,375
+76,099
| +7% | +$17.4M |
|
16
S&P Global
SPGI
$124B
| $275M | 1.01% |
689,764
-1,497
| -0.2% | -$547K |
|
17
Linde
LIN
$234B
| $243M | 0.89% |
646,735
-615
| -0.1% | -$225K |
|
18
Accenture
ACN
$84.9B
| $238M | 0.87% |
769,850
+10,875
| +1% | +$3.16M |
|
19
O'Reilly Automotive
ORLY
$71.4B
| $212M | 0.78% |
3,389,820
-29,430
| -0.9% | -$1.8M |
|
|
20
Alphabet (Google) Class A
GOOGL
$3.88T
| $206M | 0.75% |
1,723,610
-4,122
| -0.2% | -$474K |
|
21
Johnson & Johnson
JNJ
$624B
| $203M | 0.74% |
1,228,559
-156,895
| -11% | -$25.3M |
|
22
Comcast
CMCSA
$78.3B
| $194M | 0.71% |
4,674,286
-77,417
| -2% | -$3.07M |
|
|
23
Amazon
AMZN
$2.51T
| $191M | 0.7% |
1,464,824
-599,654
| -29% | -$68.5M |
|
24
Texas Pacific Land
TPL
$29.4B
| $188M | 0.69% |
1,287,252
-9,225
| -0.7% | -$1.48M |
|
25
Intercontinental Exchange
ICE
$81B
| $188M | 0.69% |
1,658,495
-36,814
| -2% | -$3.99M |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.